RPL29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.503800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.656200E-01
Normal-vs-Stage2
9.213600E-01
Normal-vs-Stage3
2.480800E-01
Normal-vs-Stage4
3.371800E-01
Stage1-vs-Stage2
5.182200E-02
Stage1-vs-Stage3
4.548200E-01
Stage1-vs-Stage4
1.430010E-01
Stage2-vs-Stage3
1.914230E-01
Stage2-vs-Stage4
4.058400E-02
Stage3-vs-Stage4
7.389600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.025600E-01
Normal-vs-AfricanAmerican
1.875440E-01
Normal-vs-Asian
7.394800E-01
Caucasian-vs-AfricanAmerican
2.428300E-02
Caucasian-vs-Asian
4.171000E-01
AfricanAmerican-vs-Asian
1.939000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.947800E-01
Normal-vs-Female
7.707400E-01
Male-vs-Female
7.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.281600E-01
Normal-vs-Age(41-60Yrs)
4.476200E-01
Normal-vs-Age(61-80Yrs)
9.411400E-01
Normal-vs-Age(81-100Yrs)
5.319400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.672400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.437400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.032580E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.378400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.568500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.215840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.775000E-01
Normal-vs-Daily Drinker
7.614800E-01
Normal-vs-Weekly Drinker
8.302400E-01
Normal-vs-Occasional Drinker
8.597800E-01
Normal-vs-Social Drinker
2.957000E-01
Non Drinker-vs-Daily Drinker
2.051800E-01
Non Drinker-vs-Weekly Drinker
4.838400E-01
Non Drinker-vs-Occasional Drinker
9.180000E-01
Non Drinker-vs-Social Drinker
2.820200E-01
Daily Drinker-vs-Weekly Drinker
9.217400E-01
Daily Drinker-vs-Occasional Drinker
3.579200E-01
Daily Drinker-vs-Social Drinker
3.770200E-02
Weekly Drinker-vs-Occasional Drinker
5.337600E-01
Weekly Drinker-vs-Social Drinker
2.613800E-01
Occasional Drinker-vs-Social Drinker
3.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.977200E-01
Normal-vs-Grade 2
8.046000E-01
Normal-vs-Grade 3
9.495200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.393900E-02
Grade 1-vs-Grade 3
3.246800E-01
Grade 1-vs-Grade 4
7.977200E-01
Grade 2-vs-Grade 3
4.639800E-01
Grade 2-vs-Grade 4
8.046000E-01
Grade 3-vs-Grade 4
9.495200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.949600E-01
Normal-vs-NonDiabetic
8.502200E-01
Diabetic-vs-NonDiabetic
5.333800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.518000E-01
Normal-vs-NoPancreatitis
8.984800E-01
Pancreatitis-vs-NoPancreatitis
7.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.343800E-01
Normal-vs-N1
9.166600E-01
N0-vs-N1
5.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.999400E-01
Normal-vs-TP53-NonMutant
6.982600E-01
TP53-Mutant-vs-TP53-NonMutant
1.719640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
